All the news Showing 10 of 1,614 articles from: Hepatitis CGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Re-treatment of hepatitis C is highly effective after the first combination fails Keith Alcorn / 24 June 2022 Two combinations proved highly effective in curing hepatitis C in people who had experienced the failure of a previous combination containing an NS5A inhibitor, studies in Europe and New Zealand show. The findings, ... Short-course treatment prevents hepatitis C after organ transplant Keith Alcorn / 24 June 2022 A seven-day course of direct-acting antiviral treatment started hours before an organ transplant prevented hepatitis C infection in everyone who received a transplant from a donor with hepatitis C, researchers from the Mayo ... People cured of hepatitis C remain at higher risk of death due to liver- and drug-related causes Keith Alcorn / 24 June 2022 People who have been cured of hepatitis C remain at higher risk of dying from liver-related causes than the general population, but their risk of cardiovascular events goes down after being cured, ... GPs could initiate treatment for chronic hepatitis C, say researchers Pulse / 03 June 2022 Self-sampling for hepatitis C improves diagnosis rate in the Netherlands Keith Alcorn / 01 June 2022 Online risk assessment for hepatitis C and home-based sampling for HCV-RNA testing proved acceptable, easy to use and resulted in a high rate of diagnosis of chronic hepatitis C infections among gay ... People with diabetes or heavy alcohol consumption at higher risk of severe fibrosis after hepatitis C cure Keith Alcorn / 18 May 2022 People with diabetes or high alcohol intake after hepatitis C cure are less likely to experience reductions in liver fibrosis after hepatitis C cure and remained at higher risk of severe liver ... High hepatitis C reinfection rate in prison study highlights harm reduction needs Keith Alcorn / 20 April 2022 Hepatitis C reinfection rates were high in Australian prisoners who took part in a study of hepatitis C treatment in prisons, researchers from the University of New South Wales report in the ... 1.2 million initiated DAA treatment for HCV between 2014 and 2020 Healio / 13 April 2022 Hepatitis C widespread but rarely treated in postpartum Medicaid beneficiaries with opioid use disorder University of Pittsburgh / 13 April 2022 Sofosbuvir/velpatasvir is suitable for treatment of genotype 4 variants in Africa Keith Alcorn / 12 April 2022 Sofosbuvir/velpatasvir is safe and effective for the treatment of hepatitis C genotype 4 variants that have naturally occurring resistance to some direct-acting antivirals in the NS5A inhibitor class, a study in Rwanda has ... ← Prev12345...162Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive